Sundaram Maria E, Christianson Ben, Alonge Oluwakemi D, Doan Melody, Ljungman Hanna, Polter Elizabeth, Steinberg Anne, Bendixsen Casper G, Williams Charnetta L, Belongia Edward A, Nguyen Huong Q, VanWormer Jeffrey J
Marshfield Clinic Research Institute, Marshfield, WI, USA.
Minnesota Department of Health, St. Paul, MN, USA.
Hum Vaccin Immunother. 2025 Dec;21(1):2508572. doi: 10.1080/21645515.2025.2508572. Epub 2025 Jun 11.
Human papillomavirus (HPV) vaccination coverage in the US is lower than other recommended adolescent vaccines. Coverage is consistently lower in rural areas, compared to urban areas. Despite this, there exists relatively little evidence on perspectives of HPV vaccination during adolescence/young adulthood. We conducted 56 interviews with young adults about their experiences, perspectives, and decision-making with HPV vaccination. Young adults aged 18-21 years who, as adolescents, may have initially refused or delayed (or their parents may have refused or delayed) and subsequently accepted HPV vaccination who resided in rural Wisconsin or urban Minnesota were eligible to participate. Interviews included questions and prompts about decision-making processes and perspectives about HPV vaccination, such as "How did you feel about the HPV vaccine before you got vaccinated?" and "What changes happened that factored into you getting the shot?" In a thematic analysis, young adults valued: information-gathering about vaccines, the opportunity to make vaccine decisions on their own (or with support of parents), and a trusting relationship with their healthcare provider. They expressed a wide range of perspectives on vaccine acceptance and hesitancy. Young adults were more concerned about needles, pain, and discomfort than other adverse outcomes following vaccination. A higher proportion of young adults in urban areas (compared to rural areas) mentioned the importance of trust in their healthcare provider. Strategies to increase HPV vaccine uptake and acceptance may consider young adults' perspectives, including the importance of the information-gathering process and relationships with their healthcare providers.
美国人类乳头瘤病毒(HPV)疫苗接种率低于其他推荐的青少年疫苗。与城市地区相比,农村地区的接种率一直较低。尽管如此,关于青少年/青年期HPV疫苗接种的观点相对缺乏证据。我们对年轻人进行了56次访谈,了解他们接种HPV疫苗的经历、观点和决策过程。年龄在18至21岁之间的年轻人,在青少年时期可能最初拒绝或推迟接种(或者他们的父母拒绝或推迟接种),随后在威斯康星州农村或明尼苏达州城市居住并接受了HPV疫苗接种的,有资格参与访谈。访谈包括关于决策过程和HPV疫苗接种观点的问题及提示,例如“在接种HPV疫苗之前你对它有什么看法?”以及“是什么变化促使你接种了疫苗?”在主题分析中,年轻人重视:收集疫苗信息、自己(或在父母支持下)做出疫苗接种决策的机会,以及与医疗服务提供者的信任关系。他们对疫苗接种接受度和犹豫态度表达了广泛的观点。与接种疫苗后的其他不良后果相比,年轻人更担心打针、疼痛和不适。城市地区的年轻人(与农村地区相比)中,更高比例的人提到了信任医疗服务提供者的重要性。提高HPV疫苗接种率和接受度的策略可能需要考虑年轻人的观点,包括信息收集过程的重要性以及与医疗服务提供者的关系。